adamantane has been researched along with Pulmonary Disease, Chronic Obstructive in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Azoulay, L; Bouganim, N; Platt, RW; Rouette, J; Yin, H; Yu, OHY | 1 |
1 other study(ies) available for adamantane and Pulmonary Disease, Chronic Obstructive
Article | Year |
---|---|
Incretin-based drugs and risk of lung cancer among individuals with type 2 diabetes.
Topics: Adamantane; Aged; Diabetes Complications; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Female; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Incidence; Incretins; Linagliptin; Liraglutide; Lung Neoplasms; Male; Middle Aged; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Risk Factors; Sitagliptin Phosphate; Smoking | 2020 |